AGENDA FOR SEPTEMBER AI, BIG DATA, AND DIGITAL HEALTH CONFERENCE 
TUESDAY, SEPTEMBER 8, 2020

All times are in Eastern Time Zone - USA

8:30am // OPENING REMARKS

8:40am // SPEAKER - Ray Chauncey, PhD, Former Director of IBM Watson Labs, Austin. Topic: Adapting Watson Principles to Real World Software Platform

9:10am // SPEAKER - Nicholas Kelley, PhD, Chief Digital Officer, Novartis.  Topic: A.I. for Life: The Novartis Data Science and AI Transformation

09:40 am // Corporate Presentation - Wellthy Therapeutics

10:00 am // Corporate Presentation - Great Bay Bio

10:20 am // Corporate Presentation - MabSilico

10:40 am // Corporate Presentation - Lunit

11:00 am // Corporate Presentation - PrecisionLife

11:20 am // Corporate Presentation - Cellworks

11:40 am // Corporate Presentation - ODS Medical

12:00 pm // Corporate Presentation - MicroMGx
12:20 pm //  Corporate Presentation - myNEO

12:40 pm //  Corporate Presentation - Imago Systems

01:00 pm // SPEAKER - Abraham Heifets, PhD, Co-Founder/CEO of Atomwise. Topic: Using AI to Lead to Drug Discovery

01:30 pm // Corporate Presentation - Etiometry

01:50 pm // Corporate Presentation - Promaxo

02:10 pm // Corporate Presentation - Varigen Biosciences

02:30 pm // Corporate Presentation - Elonic

02:50 pm // Corporate Presentation - Lantern Pharma
03:10 pm // Corporate Presentation - Curi Bio

03:30 pm // Corporate Presentation - ARTus Digital Health

03:50 pm // Corporate Presentation - Canary Speech

04:10 pm // Corporate Presentation - Path BioAnalytics

04:30 pm // Corporate Presentation - Day Zero Diagnostics

04:50 pm // SPEAKER - Lili Gil Valletta, Former Head of Multicultural Marketing at Johnson & Johnson, CEO of CEIN+ and CulturIntel (consultants to Big Pharma on using AI and Big Data to make marketing decisions). Topic: Impact of Covid in Diverse Communities and what AI reveals about Changing Behaviors

05:20 pm // SPEAKER - Fernando Schwartz, Associate Vice President, Merck. Global Data Science Leader. Topic: Challenges to Driving Profound Analytics Transformation on a Global Firm

05:50 pm // CLOSING REMARKS

WEDNESDAY, SEPTEMBER 9, 2020

All times are in Eastern Time Zone - USA

8:30am // OPENING REMARKS

8:40am // SPEAKER - Andrew Robertson, PhD, JD, Global Head of Strategy and Transformation, Digital and Data Sciences, Sanofi. Topic: Leveraging Digital and Advanced Analytics Strategies Across the R&D Enterprise

9:10am // SPEAKER - Fred Nazem, PhD, CEO, Rejuvenan Global Health, Former CEO and Chairman, Oxford Health, Founder of 7 Venture Funds Since 1970s. Topic: How Covid-19 and Increased Technology Has Led to Changes in Healthcare and Wellness Companies

09:40 am // Corporate Presentation - Cosmo Aesthetics

10:00 am // Corporate Presentation - DM Intelligence

10:20 am // Corporate Presentation - MedBeat

10:40 am // Corporate Presentation - Implandata Ophthalmic Products

11:00 am // Corporate Presentation - RxLive

11:20 am // Corporate Presentation - Cubismi

11:40am // Corporate Presentation - JOGO Health

12:00pm // Corporate Presentation - Prima-Temp
12:20 pm //  Corporate Presentation - Strados Labs

12:40 pm //  Corporate Presentation - Intercept TeleMed

01:00 pm // SPEAKER -  Nikesh Kotecha, Vice President of Informatics, Parker Institute for Cancer Research.  Topic: AI and Translation

01:30 pm // Corporate Presentation - Readout Health

01:50 pm // Corporate Presentation - Symptelligence

02:10 pm // Corporate Presentation - VitalTech

02:30 pm // Corporate Presentation - BehaVR

02:50 pm // Corporate Presentation - TRIPP

03:10 pm // Corporate Presentation - Asparia

03:30 pm // Corporate Presentation - 19Labs

03:50 pm // Corporate Presentation - Apricity Health

04:10 pm // Corporate Presentation - Thrive Bioscience

04:30 pm // Corporate Presentation - Rejuvenan

04:50 pm // SPEAKER - Shahid Shah, "Shahid Shah, "The Healthcare IT Guy", Former CTO of Cardinal Health’s CTS Business Unit. Topic: How Investors Can Spot AI BS

05:20 pm // SPEAKER - Zhaoling Meng, Global Head Clinical Modeling & Evidence Integration, Digital and Data Sciences at Sanofi. Topic: Portfolio Modeling, Prediction and Decision Leveraging Pharma Intelligence Data

05:50 pm // CLOSING REMARKS